Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Depo-Ralovera TM

Listen to the Pronunciation:

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.

Active ingredients: medroxyprogesterone

Pack: Depo-Ralovera 150 mg/mL injection, 1 mL vial

Brand name

(ARTG)

: DEPO-RALOVERA medroxyprogesterone acetate 150 mg/1 mL injection vial

Consumer Medicine Information (CMI)

Read the CMI leaflet for facts you need to know before, during and after taking your medicine.

Listen to the audio transcription of the CMI leaflet.

For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).


What this medicine is used for

(ARTG)

1. Carcinoma: Palliative treatment of recurrent and/or metastatic breast or renal cell cancer and of inoperable recurrent or metastatic endometrial carcinoma. 2. Endometriosis: For use in the treatment of visually proven (laparoscopy) endometriosis where the required end-point of treament is pregnancy, or for the control of symptoms when surgery is contra-indicated or has been unsuccessful. 3. Contraception (ovulation supression) : For long-term prevention of pregnancy in women when administered at 3-month intervals. Since loss of bone mineral density (BMD) may occur in pre-menopausal women who use DEPO-RALOVERA long-term (greater than 2 years), women should be assessed, before starting treatment for contraception or endosmetriosis, regarding the risk of osteoporosis. Women under the age of 18 Years may be at risk of failing to achive their predicted peak bone mineral density (See WARNINGS).

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

  • Injection, suspension
  • Intramuscular
  • White suspension.

Storage conditions

(ARTG)

  • Store below 30 degrees Celsius
  • Do not Freeze
  • Do not Refrigerate
  • Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.

  • 1mL X 1 pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient medroxyprogesterone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Back to top back to top

Need more information?

These trusted information partners have more on this topic.

Healthdirect 24hr 7 days a week hotline

24 hour health advice you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information and advice

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Queensland Government logo Government of South Australia, health department logo Tasmanian government logo Victorian government logo Government of Western Australia, health department logo

Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and present.

© 2025 Healthdirect Australia Limited